Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-05-12Clinical Trial Update: Bevacizumab and Low-Dose Cyclophosphamide in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial evaluating bevacizumab with low-dose cyclophosphamide in patients with recurrent ovarian epithelial cancer or primary peritone…
-
CLINICAL_TRIALS trial_result · 2015-05-08Clinical Trial Update: Polyglutamate Paclitaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer [Phase 1]
Phase 1 study of polyglutamate paclitaxel in combination with carboplatin for ovarian epithelial, fallopian tube, and primary peritoneal can…
-
CLINICAL_TRIALS trial_result · 2015-05-05Clinical Trial Update: Saracatinib and Paclitaxel in Platinum-resistant Ovarian Cancer [Phase 2, Phase 3]
A phase 2/3 trial evaluated the combination of saracatinib with paclitaxel in platinum-resistant ovarian cancer, including fallopian tube an…
-
CLINICAL_TRIALS trial_result · 2015-04-30Clinical Trial Update: Study of Gemcitabine/Carboplatin/Bevacizumab to Treat Ovarian, Fallopian Tube or Primary Peritoneal Cancer [Phase 2]
Phase 2 clinical trial evaluating the combination of gemcitabine, carboplatin, and bevacizumab for ovarian cancer, fallopian tube cancer, or…
-
CLINICAL_TRIALS trial_result · 2015-04-30Clinical Trial Update: Imatinib Mesylate in Treating Patients With Refractory or Relapsed Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer, or Ovarian Low Malignant Potential Tumor [Phase 2]
Phase 2 clinical trial update evaluating imatinib mesylate in patients with refractory or relapsed ovarian epithelial cancer, fallopian tube…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-04-30Clinical Trial Update: Immunotoxin Therapy in Treating Patients With Advanced Cancer [Phase 1]
A Phase 1 trial of immunotoxin therapy in patients with advanced cancers has completed, with results spanning several gynecologic and non-gy…
-
CLINICAL_TRIALS trial_result · 2015-04-30Clinical Trial Update: Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors [Phase 1]
Phase 1 trial of an immunotoxin therapy in patients with advanced solid tumors has completed, spanning eight cancer types including cervical…
-
CLINICAL_TRIALS trial_result · 2015-04-29Clinical Trial Update: Gene Therapy and Biological Therapy in Treating Patients With Ovarian Epithelial Cancer [Phase 1]
Phase 1 clinical trial evaluating gene therapy and biological therapy for ovarian cancer has completed. The study explored safety and prelim…
-
CLINICAL_TRIALS trial_result · 2015-04-29Clinical Trial Update: Temozolomide and O6-benzylguanine in Treating Children With Solid Tumors [Phase 1]
Phase 1 trial of temozolomide combined with O6-benzylguanine in children with solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2015-04-29Clinical Trial Update: STELLA Trial: Transperitoneal vs. Extraperitoneal Approach for Laparoscopic Staging of Endometrial/Ovarian Cancer [NA]
The STELLA trial comparing transperitoneal versus extraperitoneal laparoscopic staging for endometrial and ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2015-04-21Clinical Trial Update: Prophylactic Salpingectomy for the Prevention of the Ovarian Cancer: Comparison Between Surgical Techniques [NA]
A completed clinical trial comparing surgical techniques for prophylactic salpingectomy aimed at preventing ovarian cancer in women with ute…
-
CLINICAL_TRIALS trial_result · 2015-04-16Clinical Trial Update: Paclitaxel Plus Carboplatin With or Without SCH-58500 in Treating Patients With Newly Diagnosed Stage III Ovarian or Stage III Primary Peritoneal Cancer [Phase 2, Phase 3]
Phase 2/3 trial evaluating paclitaxel plus carboplatin with or without SCH-58500 in newly diagnosed stage III ovarian cancer or stage III pr…
-
CLINICAL_TRIALS trial_result · 2015-04-10Clinical Trial Update: Whole Body Diffusion MRI for Non-invasive Lesion Detection and Therapy Follow-up: Study With Patients With Ovarian Cancer and Peritoneal Metastasis [NA]
A completed clinical trial evaluating whole-body diffusion MRI as a non-invasive tool for detecting lesions and monitoring therapy in patien…
-
CLINICAL_TRIALS trial_result · 2015-03-26Clinical Trial Update: Sorafenib and Bevacizumab to Treat Ovarian, Fallopian and Peritoneal Cancer [Phase 2]
Phase 2 trial evaluating sorafenib in combination with bevacizumab for ovarian, fallopian tube, and primary peritoneal cancers; study comple…
-
CLINICAL_TRIALS trial_result · 2015-03-26Clinical Trial Update: BB-10901 in Treating Patients With Relapsed or Refractory Solid Tumors [Phase 1]
This Phase 1 trial of BB-10901 in relapsed or refractory solid tumors has completed, evaluating patients with ovarian cancer, Merkel cell ca…
-
CLINICAL_TRIALS trial_result · 2015-03-23Clinical Trial Update: Vitamin D for Women at Increased Risk of Developing Ovarian, Fallopian, or Primary Peritoneal Cancer [NA]
This Northwestern University-sponsored trial evaluated Vitamin D supplementation for women at increased risk of ovarian, fallopian tube, or …
-
CLINICAL_TRIALS withdrawal · 2015-03-18Clinical Trial Update: Prolonged Emend in a Study (NYU 03-67) of Oxaliplatin and Topotecan in Previously Treated Ovarian Cancer [NA]
A clinical trial evaluating prolonged Emend (aprepitant) in combination with oxaliplatin and topotecan for previously treated ovarian cancer…
-
CLINICAL_TRIALS withdrawal · 2015-03-18Clinical Trial Update: Feasibility Study of Short Term Fondaparinux (Arixtra) in Chemotherapy-Pretreated Ovarian Carcinoma Patients at High Risk of Progression [Phase 1]
A Phase 1 feasibility study of fondaparinux (Arixtra) in chemotherapy-pretreated ovarian cancer patients at high risk of progression has bee…
-
CLINICAL_TRIALS trial_result · 2015-03-10Clinical Trial Update: Pilot Study of Taxol, Carboplatin, and Bevacizumab in Advanced Stage Ovarian Carcinoma Patients [Phase 2]
A Phase 2 pilot study evaluating paclitaxel (Taxol), carboplatin, and bevacizumab in advanced ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2015-03-10Clinical Trial Update: Efficacy of NOV-002 in Combination With Carboplatin in Chemotherapy-resistant Ovarian Cancer [Phase 2]
Phase 2 trial evaluating NOV-002 with carboplatin in chemotherapy-resistant ovarian cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2015-03-10Clinical Trial Update: Safety and Efficacy Study of Glufosfamide in Ovarian Cancer [Phase 2]
Phase 2 safety and efficacy study of Glufosfamide in ovarian cancer was terminated; results were posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-03-06Clinical Trial Update: S0114 Vaccine Therapy in Treating Patients With Gastric, Prostate, or Ovarian Cancer [Phase 1]
Phase 1 clinical trial evaluating S0114 vaccine therapy in patients with brain tumors, gastric cancer, ovarian cancer, or prostate cancer ha…
-
CLINICAL_TRIALS trial_result · 2015-03-03Clinical Trial Update: A Phase II Combined Modality Protocol of Debulking Surgery With HIPEC Followed by Intraperitoneal Chemotherapy for the Treatment of Recurrent Ovarian, Primary Peritoneal & Fallopian Tube Cancers [Phase 2]
Phase II trial evaluating debulking surgery with HIPEC followed by intraperitoneal chemotherapy for recurrent ovarian, primary peritoneal, a…
-
CLINICAL_TRIALS trial_result · 2015-02-25Clinical Trial Update: AURELIA: A Study of Avastin (Bevacizumab) Added to Chemotherapy in Patients With Platinum-resistant Ovarian Cancer [Phase 3]
Phase 3 trial of Avastin added to chemotherapy for platinum-resistant ovarian cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2015-02-24Clinical Trial Update: A Study of First Line Treatment With Avastin (Bevacizumab) in Combination With Carboplatin and Weekly Paclitaxel in Patients With Ovarian Cancer [Phase 2]
Phase 2 trial of first-line ovarian cancer treatment using Avastin (bevacizumab) with carboplatin and weekly paclitaxel; results have been p…